1447 |
DES Technologies: Evolution of BioMime |
Wojciech Wojakowski |
May. 12. 11 |
1446 |
The Latest Technique in Endovascular CTO |
Hiroyoshi Yokoi |
May. 12. 11 |
1445 |
The Latest Technique in Retrograde Approach |
Yasushi Asakura |
May. 12. 11 |
1444 |
The Next Level in Antegrade Approach |
Masashi Kimura |
May. 12. 11 |
1443 |
PARTNER Percutaneous Transaortic Valve Implantation: What Have We Learned? |
Martin Bert Leon |
May. 12. 11 |
1442 |
What Are the Longer Term Results of Percutaneous Mitral Valve Repair? What Role Will It Play? |
Ted Feldman |
May. 12. 11 |
1441 |
The EXCEL Trial |
Gregg W. Stone |
May. 12. 11 |
1440 |
Pre-COMBAT: LM Disease Revascularization - PCI vs. CABG Randomization Study |
Seung-Jung Park |
May. 12. 11 |
1439 |
Reflections on the Ideal Risk-Stratification Tool: Beyond the SYNTAX Score |
Corrado Tamburino |
May. 12. 11 |
1438 |
Updated Guideline of LM PCI: Three-Year Follow-up of SYNTAX LM Subgroup Analysis |
Patrick W. Serruys |
May. 12. 11 |